| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations
|
Lohmann, Ebba
|
|
2009
|
15 |
Supplement 2 |
p. 273-276
4 p.
|
artikel
|
| 2 |
Analysis of PArkin Co-Regulated Gene in a Taiwanese–Ethnic Chinese cohort with early-onset Parkinson's disease
|
Taylor, Juliet M.
|
|
2009
|
15 |
Supplement 2 |
p. 417-421
5 p.
|
artikel
|
| 3 |
Association of a polymorphism in the ABCB1 gene with Parkinson's disease
|
Westerlund, Marie
|
|
2009
|
15 |
Supplement 2 |
p. 422-424
3 p.
|
artikel
|
| 4 |
A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction
|
Puschmann, Andreas
|
|
2009
|
15 |
Supplement 2 |
p. 627-632
6 p.
|
artikel
|
| 5 |
Avances en tratamiento medico de la enfermedad de Parkinson [Advances in the medical treatment of Parkinson's disease]
|
Chaná, Pedro
|
|
2009
|
15 |
Supplement 2 |
p. S22-S25
4 p.
|
artikel
|
| 6 |
Clinical features of LRRK2 parkinsonism
|
Haugarvoll, Kristoffer
|
|
2009
|
15 |
Supplement 2 |
p. S205-S208
4 p.
|
artikel
|
| 7 |
Clinimetric analyses of the Modified Parkinson Activity Scale
|
Keus, S.H.J.
|
|
2009
|
15 |
Supplement 2 |
p. 263-269
7 p.
|
artikel
|
| 8 |
Continuous sleep EEG monitoring in PD patients with and without sleep attacks
|
Möller, Jens Carsten
|
|
2009
|
15 |
Supplement 2 |
p. 238-241
4 p.
|
artikel
|
| 9 |
Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease
|
Kalaitzakis, M.E.
|
|
2009
|
15 |
Supplement 2 |
p. 196-204
9 p.
|
artikel
|
| 10 |
Differential regulation of microglial motility by ATP/ADP and adenosine
|
Gyoneva, Stefka
|
|
2009
|
15 |
Supplement 2 |
p. S195-S199
5 p.
|
artikel
|
| 11 |
Does autophagy worsen or improve the survival of dopaminergic neurons?
|
Pasquali, Livia
|
|
2009
|
15 |
Supplement 2 |
p. S24-S27
4 p.
|
artikel
|
| 12 |
Does melatonin help save dopaminergic cells in MPTP-treated mice?
|
Ma, Jeannine
|
|
2009
|
15 |
Supplement 2 |
p. 307-314
8 p.
|
artikel
|
| 13 |
Dopamine receptors and l-dopa-induced dyskinesia
|
Berthet, Amandine
|
|
2009
|
15 |
Supplement 2 |
p. S8-S12
5 p.
|
artikel
|
| 14 |
Dystonia: a surgeon's perspective
|
Aziz, Tipu Z.
|
|
2009
|
15 |
Supplement 2 |
p. S75-S80
6 p.
|
artikel
|
| 15 |
Editorial Board
|
|
|
2009
|
15 |
Supplement 2 |
p. i-
1 p.
|
artikel
|
| 16 |
Editorial Board
|
|
|
2009
|
15 |
Supplement 2 |
p. i-
1 p.
|
artikel
|
| 17 |
Editorial Board
|
|
|
2009
|
15 |
Supplement 2 |
p. i-
1 p.
|
artikel
|
| 18 |
Evaluation of gastric emptying in familial and sporadic Parkinson disease
|
Krygowska-Wajs, Anna
|
|
2009
|
15 |
Supplement 2 |
p. 692-696
5 p.
|
artikel
|
| 19 |
Exercise programs improve mobility and balance in people with Parkinson's disease
|
Gobbi, Lilian T.B.
|
|
2009
|
15 |
Supplement 2 |
p. S49-S52
4 p.
|
artikel
|
| 20 |
Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes
|
Hasegawa, Kazuko
|
|
2009
|
15 |
Supplement 2 |
p. 300-306
7 p.
|
artikel
|
| 21 |
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease
|
Golub, Yulia
|
|
2009
|
15 |
Supplement 2 |
p. 539-541
3 p.
|
artikel
|
| 22 |
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy
|
De Rosa, Anna
|
|
2009
|
15 |
Supplement 2 |
p. 242-244
3 p.
|
artikel
|
| 23 |
GIGYF2 mutations are not a frequent cause of familial Parkinson's disease
|
Di Fonzo, Alessio
|
|
2009
|
15 |
Supplement 2 |
p. 703-705
3 p.
|
artikel
|
| 24 |
Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism
|
Ross, Owen A.
|
|
2009
|
15 |
Supplement 2 |
p. 466-467
2 p.
|
artikel
|
| 25 |
High intensity eccentric resistance training decreases bradykinesia and improves quality of life in persons with Parkinson's disease: A preliminary study
|
Dibble, Leland E.
|
|
2009
|
15 |
Supplement 2 |
p. 752-757
6 p.
|
artikel
|
| 26 |
Integration deficiencies associated with continuous limb movement sequences in Parkinson's disease
|
Park, Jin-Hoon
|
|
2009
|
15 |
Supplement 2 |
p. 682-687
6 p.
|
artikel
|
| 27 |
Intrafamilial variability of Parkinson phenotype in SCAs: Novel cases due to SCA2 and SCA3 expansions
|
Socal, M.P.
|
|
2009
|
15 |
Supplement 2 |
p. 374-378
5 p.
|
artikel
|
| 28 |
Learning and consolidation of visuo-motor adaptation in Parkinson's disease
|
Marinelli, Lucio
|
|
2009
|
15 |
Supplement 2 |
p. 6-11
6 p.
|
artikel
|
| 29 |
Long half-life and prolonged-release dopamine receptor agonists: a review of ropinirole prolonged-release studies
|
Onofrj, M.
|
|
2009
|
15 |
Supplement 2 |
p. S85-S92
8 p.
|
artikel
|
| 30 |
LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease
|
Patra, Biswanath
|
|
2009
|
15 |
Supplement 2 |
p. 175-180
6 p.
|
artikel
|
| 31 |
LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay
|
Mata, Ignacio F.
|
|
2009
|
15 |
Supplement 2 |
p. 370-373
4 p.
|
artikel
|
| 32 |
Mechanism and treatment of dropped head syndrome associated with parkinsonism
|
Oyama, Genko
|
|
2009
|
15 |
Supplement 2 |
p. 181-186
6 p.
|
artikel
|
| 33 |
Neuropathology of non-motor features of Parkinson disease
|
Dickson, Dennis W.
|
|
2009
|
15 |
Supplement 2 |
p. S1-S5
5 p.
|
artikel
|
| 34 |
Neuroprotective and toxic changes in microglia in neurodegenerative disease
|
Sawada, Makoto
|
|
2009
|
15 |
Supplement 2 |
p. S39-S41
3 p.
|
artikel
|
| 35 |
New considerations in the medical management of early Parkinson's disease: Impact of recent clinical trials on treatment strategy
|
Hauser, Robert A.
|
|
2009
|
15 |
Supplement 2 |
p. S17-S21
5 p.
|
artikel
|
| 36 |
Non-motor symptoms in a prevalent population with Parkinson's disease in Tanzania
|
Dotchin, C.L.
|
|
2009
|
15 |
Supplement 2 |
p. 457-460
4 p.
|
artikel
|
| 37 |
O.024 Advances in the medical treatment of Parkinson's disease
|
Chana, P.
|
|
2009
|
15 |
Supplement 2 |
p. S7-
1 p.
|
artikel
|
| 38 |
O.075 Atypical parkinsonism
|
Lang, A.E.
|
|
2009
|
15 |
Supplement 2 |
p. S19-
1 p.
|
artikel
|
| 39 |
Octarepeat changes of prion protein in Parkinson's disease
|
Wang, Vinchi
|
|
2009
|
15 |
Supplement 2 |
p. 53-58
6 p.
|
artikel
|
| 40 |
O.027 Dealing with the devil in the detail - some thoughts about the next model of the basal ganglia
|
Arbuthnott, G.
|
|
2009
|
15 |
Supplement 2 |
p. S8-
1 p.
|
artikel
|
| 41 |
O.072 Dystonia
|
Schneider, S.
|
|
2009
|
15 |
Supplement 2 |
p. S19-
1 p.
|
artikel
|
| 42 |
O.010 Emergencies in PD
|
Pal, P.
|
|
2009
|
15 |
Supplement 2 |
p. S3-S4
2 p.
|
artikel
|
| 43 |
O.041 From bench to bedside: new treatments for Friedreich's ataxia
|
Pandolfo, M.
|
|
2009
|
15 |
Supplement 2 |
p. S11-
1 p.
|
artikel
|
| 44 |
O.085 Huntington disease (HD): clinical features and experimental therapeutics
|
Shoulson, I.
|
|
2009
|
15 |
Supplement 2 |
p. S22-
1 p.
|
artikel
|
| 45 |
O.080 Leucine-rich repeat kinase 2: animal models
|
Farrer, M.
|
|
2009
|
15 |
Supplement 2 |
p. S21-
1 p.
|
artikel
|
| 46 |
O.099 Low frequency stimulation of PPTg in PD: minor beneflts on gait, peculiar changes of cortical metabolism and cognitive performance
|
Stefani, A.
|
|
2009
|
15 |
Supplement 2 |
p. S26-
1 p.
|
artikel
|
| 47 |
Opening velocity, a novel parameter, for finger tapping test in patients with Parkinson's disease
|
Yokoe, M.
|
|
2009
|
15 |
Supplement 2 |
p. 440-444
5 p.
|
artikel
|
| 48 |
Osteoporosis in Parkinson's disease
|
Invernizzi, Marco
|
|
2009
|
15 |
Supplement 2 |
p. 339-346
8 p.
|
artikel
|
| 49 |
O.058 Will continuous dopamine stimulation prevent motor complications?
|
Antonini, A.
|
|
2009
|
15 |
Supplement 2 |
p. S15-
1 p.
|
artikel
|
| 50 |
P3.042 A GATA-2-switch model of a-synuclein overexpression in sporadic Parkinson's disease
|
Liao, Z.
|
|
2009
|
15 |
Supplement 2 |
p. S159-
1 p.
|
artikel
|
| 51 |
P3.156 Alcohol dehydrogenase 2 polymorphism is not associated to the risk for essential tremor
|
Martinez-Oliva, C.
|
|
2009
|
15 |
Supplement 2 |
p. S188-
1 p.
|
artikel
|
| 52 |
P2.058 Anatomical localization of active contacts of deep brain electrodes – technical note
|
Urgosik, D.
|
|
2009
|
15 |
Supplement 2 |
p. S104-
1 p.
|
artikel
|
| 53 |
P2.092 A randomized, double-blind evaluation of levodopa/carbidopa/entacapone versus immediate-release levodopa/carbidopa in patients with Parkinson's disease exhibiting nonmotor symptoms of wearing off
|
Stacy, M.
|
|
2009
|
15 |
Supplement 2 |
p. S113-S114
2 p.
|
artikel
|
| 54 |
PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease
|
Zimprich, Alexander
|
|
2009
|
15 |
Supplement 2 |
p. 532-534
3 p.
|
artikel
|
| 55 |
P2.106 Assessment of symptomatic and neuroprotective efflcacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease
|
Pinna, A.
|
|
2009
|
15 |
Supplement 2 |
p. S117-
1 p.
|
artikel
|
| 56 |
P1.174 A successful computer method for assessing drawing impairment in Parkinson's disease
|
Westin, J.
|
|
2009
|
15 |
Supplement 2 |
p. S73-S74
2 p.
|
artikel
|
| 57 |
P1.184 Behavioral disturbances in Parkinson's disease: a study from Slovak movement disorders center
|
Martinková, J.
|
|
2009
|
15 |
Supplement 2 |
p. S76-
1 p.
|
artikel
|
| 58 |
P2.017 Behavioural and biochemical characterization of c-Rel mutant mice as model of Parkinson's disease
|
Pinna, A.
|
|
2009
|
15 |
Supplement 2 |
p. S92-
1 p.
|
artikel
|
| 59 |
P1.071 Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy
|
Teive, H.
|
|
2009
|
15 |
Supplement 2 |
p. S47-
1 p.
|
artikel
|
| 60 |
P3.119 Characteristics of resting-state oscillatory activity in the basal ganglia-cortical loop in the 6-OHDA-lesioned rat models of Parkinson's disease
|
Li, M.
|
|
2009
|
15 |
Supplement 2 |
p. S178-S179
2 p.
|
artikel
|
| 61 |
P3.146 Clinical and MRI correlations in Parkinson's disease patients with headache
|
Verulashvili, I.
|
|
2009
|
15 |
Supplement 2 |
p. S185-S186
2 p.
|
artikel
|
| 62 |
P3.016 Cognitive features are more predictive of corticobasal degeneration (CBD) pathology than motor features in corticobasal syndrome
|
Kranick, S.
|
|
2009
|
15 |
Supplement 2 |
p. S152-
1 p.
|
artikel
|
| 63 |
P2.195 Color vision and Parkinson's disease; comparison with essential tremor and controls
|
Kim, J.-S.
|
|
2009
|
15 |
Supplement 2 |
p. S142-
1 p.
|
artikel
|
| 64 |
P3.160 Communication circles – a cost effective model of on-going speech therapy for individuals with Parkinson's disease
|
Bereskin, B.
|
|
2009
|
15 |
Supplement 2 |
p. S189-
1 p.
|
artikel
|
| 65 |
P3.082 Covalent modiflcation of superoxide dismutase 2 by dopamine oxidation products
|
Belluzzi, E.
|
|
2009
|
15 |
Supplement 2 |
p. S169-
1 p.
|
artikel
|
| 66 |
P1.126 Developing a risk model for Parkinson disease
|
Chung, R.-H.
|
|
2009
|
15 |
Supplement 2 |
p. S61-
1 p.
|
artikel
|
| 67 |
P1.023 Development of task switching and error monitoring in children
|
Gupta, R.
|
|
2009
|
15 |
Supplement 2 |
p. S34-S35
2 p.
|
artikel
|
| 68 |
P1.054 Effectiveness of learning based training memory and sensorimotor training for patients with focal hand dystonia
|
McKenzie, A.
|
|
2009
|
15 |
Supplement 2 |
p. S42-S43
2 p.
|
artikel
|
| 69 |
P3.054 Effect of prenatal manganese intoxication on dopaminergic neurotranssmision in the brain of rats lesioned as neonates with 6-hydroxydopamine
|
Nowak, P.
|
|
2009
|
15 |
Supplement 2 |
p. S162-
1 p.
|
artikel
|
| 70 |
P1.081 Effects of auditory, attentional, and combined cueing strategies on gait during single and dual cognitive tasks in Parkinson's disease
|
Lohnes, C.A.
|
|
2009
|
15 |
Supplement 2 |
p. S49-S50
2 p.
|
artikel
|
| 71 |
P1.129 End of life in Parkinson's disease
|
Feve, A.
|
|
2009
|
15 |
Supplement 2 |
p. S62-
1 p.
|
artikel
|
| 72 |
Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity
|
Chou, Kelvin L.
|
|
2009
|
15 |
Supplement 2 |
p. 640-643
4 p.
|
artikel
|
| 73 |
P1.040 Executive and memory decline in a longitudinally followed group of non-demented patients with idiopathic Parkinson's disease
|
Zhelev, Y.
|
|
2009
|
15 |
Supplement 2 |
p. S39-
1 p.
|
artikel
|
| 74 |
P3.143 Ferroportin1 but not hephaestin was involved in the 6-hydroxydopamine induced iron accumulation in primary ventral mesencephalic neurons and MES23.5 cells
|
Song, N.
|
|
2009
|
15 |
Supplement 2 |
p. S185-
1 p.
|
artikel
|
| 75 |
P3.030 GBA mutations and Parkinson disease in Italian population
|
D'Angelo, R.
|
|
2009
|
15 |
Supplement 2 |
p. S155-S156
2 p.
|
artikel
|
| 76 |
Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: A prospective study
|
Cooper, Alex D.
|
|
2009
|
15 |
Supplement 2 |
p. 59-61
3 p.
|
artikel
|
| 77 |
P1.143 How important is unrelated co-morbidity in Parkinson's disease?
|
Leckie, K.
|
|
2009
|
15 |
Supplement 2 |
p. S65-
1 p.
|
artikel
|
| 78 |
P1.215 Indian variant PSP-P: clinical and quantitative MRI proflle
|
Nehru, R.
|
|
2009
|
15 |
Supplement 2 |
p. S84-
1 p.
|
artikel
|
| 79 |
P2.034 Intraoperative stereotactic accuracy of the FHC microTargeting and Axon Instruments microdrives compared
|
Ahmed, S.
|
|
2009
|
15 |
Supplement 2 |
p. S97-
1 p.
|
artikel
|
| 80 |
P1.110 123I-/V-cu-fluoro-propyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane ([123I] FP-CIT) SPECT in cases of multiple system atrophy
|
Gontu, V.
|
|
2009
|
15 |
Supplement 2 |
p. S57-
1 p.
|
artikel
|
| 81 |
Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia
|
Cenci, M. Angela
|
|
2009
|
15 |
Supplement 2 |
p. S59-S63
5 p.
|
artikel
|
| 82 |
P3.174 Laughing during sleep as a manifestation of rapid eye movement sleep behaviour disorder
|
Siclari, F.
|
|
2009
|
15 |
Supplement 2 |
p. S193-
1 p.
|
artikel
|
| 83 |
P2.020 Lipopolysaccharide rat model for Parkinson's disease neurodegeneration: disease-associated proteins, cytokines and inflammatory cells in brain tissue
|
Schiess, M.
|
|
2009
|
15 |
Supplement 2 |
p. S93-
1 p.
|
artikel
|
| 84 |
P3.191 LRRK2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
|
Qing, H.
|
|
2009
|
15 |
Supplement 2 |
p. S197-
1 p.
|
artikel
|
| 85 |
P2.140 Meta-analysis of DBS surgery in patients with advanced Parkinson's disease
|
Ives, N.
|
|
2009
|
15 |
Supplement 2 |
p. S127-
1 p.
|
artikel
|
| 86 |
P1.098 Microstructural integrity of white matter in patients with Parkinson's disease (PD): diffusion tensor imaging and MR-tractography study
|
Rozhkova, Z.
|
|
2009
|
15 |
Supplement 2 |
p. S54-
1 p.
|
artikel
|
| 87 |
P3.102 Mitochondrial defects induced by a loss of fusion effect in mutant PINK1 can be rescued through the flssion/fusion pathway
|
Cui, M.
|
|
2009
|
15 |
Supplement 2 |
p. S174-
1 p.
|
artikel
|
| 88 |
P1.006 Neurochemical and neuroplastic changes in chronic methyphenidate administered brains
|
Sadasivan, S.
|
|
2009
|
15 |
Supplement 2 |
p. S30-
1 p.
|
artikel
|
| 89 |
P3.088 Nicotinamide dosage regulates redox [NAD(H)] and is relevant to pellagra, brain development and diseases of ageing including dementia and parkinsonism
|
Williams, A.C.
|
|
2009
|
15 |
Supplement 2 |
p. S171-
1 p.
|
artikel
|
| 90 |
P3.065 Nimesulide, a preferential cyclooxygenase-2 inhibitor exhibits neuroprotection against MPTP-induced striatal lesions in rats: behavioral, biochemical, cellular and histological evidences
|
Gupta, A.
|
|
2009
|
15 |
Supplement 2 |
p. S165-
1 p.
|
artikel
|
| 91 |
P3.040 Non synonymous GIGYF2 variants in Parkinson's disease
|
Prakash, K.M.
|
|
2009
|
15 |
Supplement 2 |
p. S158-
1 p.
|
artikel
|
| 92 |
P3.085 Novel bio-panning technique to isolate scFv against low concentrations of toxic natural brain derived Abeta oligomers
|
Kasturirangan, S.
|
|
2009
|
15 |
Supplement 2 |
p. S170-
1 p.
|
artikel
|
| 93 |
P2.109 Piclozotan reduces dyskinesia and OFF time in Parkinson's disease (PD) patients with L-dopa induced motor complications
|
Hauser, R.A.
|
|
2009
|
15 |
Supplement 2 |
p. S118-
1 p.
|
artikel
|
| 94 |
P3.039 Polymorphisms in the transcription factor gene GATA2 and GATA-2 target region in a-synuclein (SNCA) are associated with Parkinson's disease (PD)
|
Kay, D.
|
|
2009
|
15 |
Supplement 2 |
p. S158-
1 p.
|
artikel
|
| 95 |
P1.103 Predictors of impulse control disorders in MMPI-2 in patients suffering from Parkinson's disease: a pilot study
|
Farnikova, K.
|
|
2009
|
15 |
Supplement 2 |
p. S55-
1 p.
|
artikel
|
| 96 |
P3.071 Protonopathies: deflciency or excess of proton providers and carriers (glucose and nicotinamide) may overwhelm NAD recycling and “short circuit” defenses
|
Williams, A.C.
|
|
2009
|
15 |
Supplement 2 |
p. S166-S167
2 p.
|
artikel
|
| 97 |
P2.178 Quality of life in patient with Parkinson's disease in Russia
|
Guekht, A.
|
|
2009
|
15 |
Supplement 2 |
p. S138-
1 p.
|
artikel
|
| 98 |
P3.133 Regulation of movement energetic costs is impaired in basal ganglia disorders
|
Moisello, C.
|
|
2009
|
15 |
Supplement 2 |
p. S182-
1 p.
|
artikel
|
| 99 |
P3.181 Restless Arms syndrome: report of 2 cases
|
Munhoz, R.P.
|
|
2009
|
15 |
Supplement 2 |
p. S194-
1 p.
|
artikel
|
| 100 |
P2.123 Ropinirole prolonged release improves nocturnal symptoms in patients with advanced Parkinson's disease: an analysis of grouped items on the PDSS
|
Chaudhuri, K.R.
|
|
2009
|
15 |
Supplement 2 |
p. S122-S123
2 p.
|
artikel
|
| 101 |
P2.150 Ropinirole prolonged release improves nocturnal symptoms in patients with advanced Parkinson's disease: an analysis of individual items on the PDSS
|
Ondo, W.
|
|
2009
|
15 |
Supplement 2 |
p. S130-
1 p.
|
artikel
|
| 102 |
P2.164 Ropinirole prolonged release maintains an increase in daily awake time spent “on” in patients with advanced Parkinson's disease
|
Stocchi, F.
|
|
2009
|
15 |
Supplement 2 |
p. S134-
1 p.
|
artikel
|
| 103 |
Pros and cons of apomorphine and l-dopa continuous infusion in advanced Parkinson's disease
|
Antonini, Angelo
|
|
2009
|
15 |
Supplement 2 |
p. S97-S100
4 p.
|
artikel
|
| 104 |
P1.218 Safety, tolerability and pharmacokinetics of Cogane™ (PYM50028) studied over 28 days in healthy subjects and patients with mild-moderate Parkinson's disease
|
Priestley, A.
|
|
2009
|
15 |
Supplement 2 |
p. S85-
1 p.
|
artikel
|
| 105 |
P2.048 Screening and selection process for deep brain stimulation: the Emory experience
|
Revuelta, G.J.
|
|
2009
|
15 |
Supplement 2 |
p. S101-
1 p.
|
artikel
|
| 106 |
P2.003 Selective spatial learning impairments and attention deflcits precede a frank motor phenotype in a mouse model of Parkinson's disease
|
Browne, S.E.
|
|
2009
|
15 |
Supplement 2 |
p. S89-
1 p.
|
artikel
|
| 107 |
P1.157 Sensitivity to change of quality of life rating scales used in the PD MED trial
|
Patel, S.
|
|
2009
|
15 |
Supplement 2 |
p. S69-
1 p.
|
artikel
|
| 108 |
P1.160 Signifacance of asymmetrical onset of symptoms in Parkinson's disease
|
Pokharel, D.
|
|
2009
|
15 |
Supplement 2 |
p. S70-
1 p.
|
artikel
|
| 109 |
P3.013 Sirtuin inhibitors rescue synuclein toxicity: the natural inhibitor cicotinamide cured parkinsonism in pellagrins yet may be a Jekyll and Hyde
|
Williams, A.C.
|
|
2009
|
15 |
Supplement 2 |
p. S151-
1 p.
|
artikel
|
| 110 |
P3.177 Sleep-related falling out of bed (SFOB) in Parkinson's disease. A descriptive analysis
|
Carvalho, D.
|
|
2009
|
15 |
Supplement 2 |
p. S193-S194
2 p.
|
artikel
|
| 111 |
P2.137 Somatodendritic serotonin-1A receptor responsiveness in the attenuation of apomorphine-induced sensitization by buspirone
|
Ikram, H.
|
|
2009
|
15 |
Supplement 2 |
p. S126-
1 p.
|
artikel
|
| 112 |
P1.095 Spinocerebellar ataxia 3 presenting as Parkinson disease – case series
|
Mendonça, N.
|
|
2009
|
15 |
Supplement 2 |
p. S53-
1 p.
|
artikel
|
| 113 |
P2.075 Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage
|
Wu, H.-M.
|
|
2009
|
15 |
Supplement 2 |
p. S109-
1 p.
|
artikel
|
| 114 |
P1.112 Symmetric Parkinson's disease and atypical degenerative parkinsonism: common and differential aspects
|
Moscovich, M.
|
|
2009
|
15 |
Supplement 2 |
p. S57-S58
2 p.
|
artikel
|
| 115 |
P3.034 The analysis of LRRK 2 and parkin gene mutations in Slovakia
|
Kracunova, K.
|
|
2009
|
15 |
Supplement 2 |
p. S156-S157
2 p.
|
artikel
|
| 116 |
P2.212 The impact of postural alterations and falls in the quality of life in patients with Parkinson's disease
|
Maki, T.
|
|
2009
|
15 |
Supplement 2 |
p. S147-
1 p.
|
artikel
|
| 117 |
P1.037 The importance of oxidative stress in dementia progression
|
Padurariu, M.
|
|
2009
|
15 |
Supplement 2 |
p. S38-
1 p.
|
artikel
|
| 118 |
P3.057 The roles of iron, Mn, zinc on the PD development? Relationship between food intake and serum concentrations
|
Tan, X.
|
|
2009
|
15 |
Supplement 2 |
p. S163-
1 p.
|
artikel
|
| 119 |
P1.009 The utilization of a caregiver questionnaire in an outpatient movement disorder clinic to examine and address caregiver distress
|
Book, E.
|
|
2009
|
15 |
Supplement 2 |
p. S31-
1 p.
|
artikel
|
| 120 |
P2.061 The value of MRI in the early disease stages of parkinsonian disorders: a prospective three year follow-up study
|
Abdo, W.
|
|
2009
|
15 |
Supplement 2 |
p. S105-
1 p.
|
artikel
|
| 121 |
P2.181 Time geography and quality of life for persons with Parkinson's disease
|
Mcnulty, T.
|
|
2009
|
15 |
Supplement 2 |
p. S139-
1 p.
|
artikel
|
| 122 |
P1.201 Wilson disease in young adolescent with hepatitis C – case report
|
Boshkovski, B.
|
|
2009
|
15 |
Supplement 2 |
p. S80-S81
2 p.
|
artikel
|
| 123 |
Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease
|
Yokochi, Masayuki
|
|
2009
|
15 |
Supplement 2 |
p. S25-S30
6 p.
|
artikel
|
| 124 |
Serum inflammatory biomarkers in Parkinson's disease
|
Dufek, M.
|
|
2009
|
15 |
Supplement 2 |
p. 318-320
3 p.
|
artikel
|
| 125 |
The prognosis of fixed dystonia: A follow-up study
|
Ibrahim, N.M.
|
|
2009
|
15 |
Supplement 2 |
p. 592-597
6 p.
|
artikel
|
| 126 |
Transdermal delivery of dopamine receptor agonists
|
Reichmann, Heinz
|
|
2009
|
15 |
Supplement 2 |
p. S93-S96
4 p.
|
artikel
|
| 127 |
Treatment of dysautonomia associated with Parkinson's disease
|
Mostile, Giovanni
|
|
2009
|
15 |
Supplement 2 |
p. S224-S232
9 p.
|
artikel
|
| 128 |
Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency
|
Zigmond, Michael J.
|
|
2009
|
15 |
Supplement 2 |
p. S42-S45
4 p.
|
artikel
|
Tijdschrift beschrijving